logo-loader
viewAvita Medical Ltd

Avita Medical receives regulatory update

au_medical_chart350_54163c21841ce.jpg

Regenerative medicine company Avita Medical (ASX:AVH) has been granted a trading halt this morning with its shares placed in pre-open.

Avita requested the halt after it received a regulatory update.

Avita develops and distributes regenerative products for the treatment of a broad range of wounds, scars and skin defects.

The company’s patented and proprietary tissue‐culture, collection and application technology provides treatment solutions derived from a patient’s own skin.

The halt will remain in place until the opening of trade on Wednesday 17th September 2014, or earlier if an announcement is made to the market.

 

Proactive Investors Australia is the market leader in producing news, articles and research reports on ASX “Small and Mid-cap” stocks with distribution in Australia, UK, North America and Hong Kong / China.

Quick facts: Avita Medical Ltd

Price: 0.49 AUD

ASX:AVH
Market: ASX
Market Cap: $1.05 billion
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Xpediator PLC's CFO Robert Ross and COO of Logistics Romania to step up as...

Xpediator PLC's (LON:XPD) CFO Robert Ross speaks to Proactive's Andrew Scott following the news chief executive Stephen Blyth will step down from the position. Blyth will continue as a director in the position of founder and non-executive deputy chairman. While the search for a permanent...

1 day, 6 hours ago

2 min read